Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer

Luteolin is effective in the non-small cell lung cancer model with L858R/T790M EGF receptor mutation and erlotinib resistance

(2014) Zhuan Hong et al.   BRITISH JOURNAL OF PHARMACOLOGY

Luteolin 8-C-β-fucopyranoside inhibits invasion and suppresses TPA-induced MMP-9 and IL-8 via ERK/AP-1 and ERK/NF-κB signaling in MCF-7 breast cancer cells

(2013) Su-Ho Park et al.   BIOCHIMIE

Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells

(2013) Guangliang Li et al.   Molecular Oncology

In vitro regulation of hepatocellular carcinoma cell viability, apoptosis, invasion, and AEG-1 expression by LY294002

(2013) Jian Ma et al.   Clinics and Research in Hepatology and Gastroenterology

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome

(2012) H E Lee et al.   BRITISH JOURNAL OF CANCER

Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases

(2012) Ketao Jin et al.   CANCER BIOLOGY & THERAPY

Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells

(2012) Eun-Ju Lee et al.   FOOD AND CHEMICAL TOXICOLOGY

MET Activation Mediates Resistance to Lapatinib Inhibition of HER2-Amplified Gastric Cancer Cells

(2012) C.-T. Chen et al.   MOLECULAR CANCER THERAPEUTICS

Patient-derived tumour xenografts as models for oncology drug development

(2012) John J. Tentler et al.   Nature Reviews Clinical Oncology

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Assessment of a Novel VEGF Targeted Agent Using Patient-Derived Tumor Tissue Xenograft Models of Colon Carcinoma with Lymphatic and Hepatic Metastases

(2011) Ketao Jin et al.   PLoS One

Blocking of PI3K/AKT induces apoptosis by its effect on NF-κB activity in gastric carcinoma cell line SGC7901

(2010) Xu Chao et al.   BIOMEDICINE & PHARMACOTHERAPY

Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt–GSK-3β–Cyclin D1 pathway

(2010) Chye-Sun Ong et al.   CANCER LETTERS

ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence

(2009) Sebastien Cagnol et al.   FEBS Journal

Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin

(2009) Q. Zhou et al.   MOLECULAR CANCER THERAPEUTICS

Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation

(2009) D. T. Coleman et al.   MOLECULAR CANCER THERAPEUTICS

Targeting the phosphoinositide 3-kinase pathway in cancer

(2009) Pixu Liu et al.   NATURE REVIEWS DRUG DISCOVERY

Effects of LY294002 on the invasiveness of human gastric cancer in vivo in nude mice

(2009) Chun-Gen Xing et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line

(2008) Bin Wu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY